BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28568708)

  • 21. ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.
    Zhu G; Liao X; Han C; Liu X; Yu L; Qin W; Lu S; Su H; Chen Z; Liu Z; Liang Y; Huang J; Yu T; Yang C; Huang K; Shang L; Ye X; Li L; Qin X; Xiao K; Peng M; Peng T
    Oncol Rep; 2017 Sep; 38(3):1451-1463. PubMed ID: 28714006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of genomic changes in hepatitis B virus on postoperative recurrence and survival in patients with hepatocellular carcinoma.
    Mathews P; Lee D; Chung YH; Kim JA; Lee JH; Jin YJ; Park W; Lyu H; Jaffee E; Zheng L; Yu E; Lee YJ
    Ann Surg Oncol; 2013 Apr; 20(4):1216-22. PubMed ID: 23104706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.
    Kao WY; Su CW; Chau GY; Lui WY; Wu CW; Wu JC
    World J Surg; 2011 Apr; 35(4):858-67. PubMed ID: 21207029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.
    Zhu Q; Yuan B; Qiao GL; Yan JJ; Li Y; Duan R; Yan YQ
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):418-27. PubMed ID: 26823044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of Preoperative Antiviral Treatment of Patients with HCC Negative for HBV-DNA.
    Liu XF; Zhang T; Tang K; Sui LL; Xu G; Liu Q
    Anticancer Res; 2017 Aug; 37(8):4701-4706. PubMed ID: 28739774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
    Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z
    Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma.
    Liu L; An J; Liu J; Wen J; Zhai X; Liu Y; Pan S; Jiang J; Wen Y; Liu Z; Zhang Y; Chen J; Xing J; Ji G; Shen H; Hu Z; Fan Z
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E148-54. PubMed ID: 23868705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
    Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
    Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.
    Li Z; Li N; Li F; Zhou Z; Sang J; Jin Z; Liu H; Han Q; Lv Y; Liu Z
    Oncotarget; 2016 May; 7(18):26168-80. PubMed ID: 27034168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATXN7 Gene Variants and Expression Predict Post-Operative Clinical Outcomes in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Han C; Yu L; Liu X; Yu T; Qin W; Liao X; Liu Z; Lu S; Chen Z; Su H; Zhu G; Qin X; Gui Y; Li J; Xiao K; Chen X; Ye X; Peng M; Dong J; Peng T
    Cell Physiol Biochem; 2016; 39(6):2427-2438. PubMed ID: 27855399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between novel genetic variants of Notch signaling pathway genes and survival of hepatitis B virus-related hepatocellular carcinoma.
    Qin L; Qiu M; Lin Q; Jiang B; Zhan S; Wei X; Wei J; Liu Y; Wen Q; Chen P; Jiang Y; Zhou Z; Liang X; Cao J; Gong Y; Wei Y; Wei X; Yu H
    Cancer Med; 2024 Apr; 13(7):e7040. PubMed ID: 38562021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of type 2 diabetes mellitus with incidences of microvascular invasion and survival outcomes in hepatitis B virus-related hepatocellular carcinoma after liver resection: A multicenter study.
    Zhang XP; Chai ZT; Feng JK; Zhu HM; Zhang F; Hu YR; Zhong CQ; Chen ZH; Wang K; Shi J; Guo WX; Chen CS; Wu MC; Lau WY; Cheng SQ
    Eur J Surg Oncol; 2022 Jan; 48(1):142-149. PubMed ID: 34452770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
    Cheong JY; Shin HD; Cho SW; Kim YJ
    J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
    Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
    J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variants in de novo lipogenic pathway genes predict the prognosis of surgically-treated hepatocellular carcinoma.
    Jiang H; Dai J; Huang X; Chen Y; Qu P; Li J; Yi C; Yang Y; Zhang K; Huang Q
    Sci Rep; 2015 Mar; 5():9536. PubMed ID: 25826294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of preoperative liver stiffness measurements in primary HBV-positive hepatocellular carcinoma.
    Qi M; Chen Y; Zhang GQ; Meng YJ; Zhao FL; Wang J; Ma J
    Future Oncol; 2017 Dec; 13(30):2799-2810. PubMed ID: 29189041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study.
    Yamamoto M; Kobayashi T; Mashima H; Miki D; Kuroda S; Hamaoka M; Aikata H; Chayama K; Ohdan H
    Int J Surg; 2020 Aug; 80():84-90. PubMed ID: 32615319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.